Background: Randomized clinical trials of oral antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention have widely divergent efficacy estimates, ranging from 0 % to 75%. These discrepancies are likely due to differences in adherence. To our knowledge, no studies to date have examined the impact of improving adherence through monitoring and/or intervention, which may increase PrEP efficacy, or reported on objective behavioral measures of adherence, which can inform PrEP effectiveness and implementation. Methods and Findings: Within the Partners PrEP Study (a randomized placebo-controlled trial of oral tenofovir an
Background: Efficacy of oral pre-exposure prophylaxis (PrEP) in prevention of HIV acquisition has be...
Introduction: Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the risk of HI...
Abstract Introduction Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the ri...
Randomized clinical trials of oral antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention...
Abstract Introduction: Adherence is essential for pre-exposure prophylaxis (PrEP) to protect against...
Thesis (Master's)--University of Washington, 2015Levels of adherence varied across trials for pre-ex...
For pre-exposure prophylaxis (PrEP) and microbicides to effectively prevent HIV, optimal treatment a...
Background: Several clinical trials have demonstrated the safety and effectiveness of oral tenofovir...
Background: The HIV epidemic in the United States (US) disproportionately affects gay, bisexual, and...
Effectiveness of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention will require high...
Background: There are 34 million people living with human immunodeficiency virus (HIV) worldwide and...
Thesis (Ph.D.)--University of Washington, 2018HIV incidence remains disproportionately high for wome...
BackgroundPre-exposure prophylaxis (PrEP) is highly effective and an important prevention tool for A...
Jessica Haberer and colleagues investigate the association between high adherence to antiretroviral ...
The HIV prevention field has made progress in the use of oral pre-exposure prophylaxis (PrEP) and to...
Background: Efficacy of oral pre-exposure prophylaxis (PrEP) in prevention of HIV acquisition has be...
Introduction: Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the risk of HI...
Abstract Introduction Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the ri...
Randomized clinical trials of oral antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention...
Abstract Introduction: Adherence is essential for pre-exposure prophylaxis (PrEP) to protect against...
Thesis (Master's)--University of Washington, 2015Levels of adherence varied across trials for pre-ex...
For pre-exposure prophylaxis (PrEP) and microbicides to effectively prevent HIV, optimal treatment a...
Background: Several clinical trials have demonstrated the safety and effectiveness of oral tenofovir...
Background: The HIV epidemic in the United States (US) disproportionately affects gay, bisexual, and...
Effectiveness of antiretroviral pre-exposure prophylaxis (PrEP) for HIV prevention will require high...
Background: There are 34 million people living with human immunodeficiency virus (HIV) worldwide and...
Thesis (Ph.D.)--University of Washington, 2018HIV incidence remains disproportionately high for wome...
BackgroundPre-exposure prophylaxis (PrEP) is highly effective and an important prevention tool for A...
Jessica Haberer and colleagues investigate the association between high adherence to antiretroviral ...
The HIV prevention field has made progress in the use of oral pre-exposure prophylaxis (PrEP) and to...
Background: Efficacy of oral pre-exposure prophylaxis (PrEP) in prevention of HIV acquisition has be...
Introduction: Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the risk of HI...
Abstract Introduction Oral pre-exposure prophylaxis (PrEP) is an effective strategy to reduce the ri...